Suppr超能文献

代谢综合征与韩国人群胆石症发病的相关性。

Association between metabolic syndrome and incidence of cholelithiasis in the Korean population.

机构信息

Department of Occupational and Environmental Medicine, Kyung Hee University Hospital, Seoul, Korea.

Department of Preventive Medicine, School of Medicine, Kyung Hee University, Seoul, Korea.

出版信息

J Gastroenterol Hepatol. 2021 Dec;36(12):3524-3531. doi: 10.1111/jgh.15568. Epub 2021 Jun 17.

Abstract

BACKGROUND AND AIM

Cholelithiasis is one of the most common gastrointestinal diseases worldwide. The metabolic syndrome (MetS), a combination of various metabolic abnormalities, is also common with a continually increasing prevalence. These diseases are associated with several risk factors. However, data on the association between MetS components and cholelithiasis are insufficient. This study aimed to analyze the association of MetS and its components with the incidence of cholelithiasis using national data from the Korean population.

METHODS

Data were obtained from the National Health Insurance Corporation of Korea, and 207 850 individuals without cholelithiasis in 2009 were enrolled and followed up until 2013. A multivariate Cox proportional hazard model was used to calculate the adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for the incidence of cholelithiasis according to the presence of MetS and the number of MetS components. Furthermore, the risk of cholelithiasis was evaluated in individuals with a single metabolic component.

RESULTS

The multivariate adjusted HRs and 95% CIs for incident cholelithiasis according to 1, 2, 3, and 4-5 MetS components were 1.08 (0.93-1.24), 1.22 (1.06-1.41), 1.35 (1.17-1.57), and 1.35 (1.15-1.57), respectively (P < 0.001). This increasing trend was observed in both sexes. Compared with participants with no metabolic components, those with low high-density lipoprotein (HDL) cholesterol had a significantly increased risk for cholelithiasis (adjusted HR, 1.39 [95% CI, 1.05-1.85]).

CONCLUSIONS

Metabolic syndrome is a potential risk factor for cholelithiasis. Low HDL cholesterol level is the most relevant factor among MetS components for incident cholelithiasis.

摘要

背景与目的

胆石症是全球最常见的胃肠道疾病之一。代谢综合征(MetS)是多种代谢异常的组合,其患病率也在不断增加。这些疾病与多种危险因素有关。然而,关于 MetS 成分与胆石症之间的关联的数据还不够充分。本研究旨在利用韩国人群的国家数据,分析 MetS 及其成分与胆石症发病的相关性。

方法

数据来自韩国国民健康保险公社,共纳入 2009 年无胆石症的 207850 名个体,并随访至 2013 年。采用多变量 Cox 比例风险模型,根据 MetS 的存在情况和 MetS 成分的数量,计算胆石症发病的调整后危险比(HR)和 95%置信区间(CI)。此外,还评估了单个代谢成分个体的胆石症发病风险。

结果

根据存在 1、2、3 和 4-5 个 MetS 成分,发生胆石症的多变量调整 HR 和 95%CI 分别为 1.08(0.93-1.24)、1.22(1.06-1.41)、1.35(1.17-1.57)和 1.35(1.15-1.57)(P<0.001)。这种趋势在男女两性中均观察到。与没有代谢成分的参与者相比,低高密度脂蛋白(HDL)胆固醇的参与者发生胆石症的风险显著增加(调整 HR,1.39[95%CI,1.05-1.85])。

结论

代谢综合征是胆石症的一个潜在危险因素。在 MetS 成分中,低 HDL 胆固醇水平是与胆石症发病最相关的因素。

相似文献

1
Association between metabolic syndrome and incidence of cholelithiasis in the Korean population.
J Gastroenterol Hepatol. 2021 Dec;36(12):3524-3531. doi: 10.1111/jgh.15568. Epub 2021 Jun 17.
4
Metabolic syndrome, metabolic components, and their relation to the risk of pancreatic cancer.
Cancer. 2020 Jan 1;126(9):1979-1986. doi: 10.1002/cncr.32737. Epub 2020 Feb 3.
5
Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study.
PLoS Med. 2018 Aug 21;15(8):e1002640. doi: 10.1371/journal.pmed.1002640. eCollection 2018 Aug.
6
Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study.
Cancer. 2022 Mar 15;128(6):1230-1241. doi: 10.1002/cncr.34027. Epub 2021 Nov 11.
8
Association of metabolic syndrome with the incidence of hearing loss: A national population-based study.
PLoS One. 2019 Jul 26;14(7):e0220370. doi: 10.1371/journal.pone.0220370. eCollection 2019.
10
Metabolic syndrome and the risk of abdominal aortic aneurysm: A nationwide cohort study.
Atherosclerosis. 2023 Dec;386:117329. doi: 10.1016/j.atherosclerosis.2023.117329. Epub 2023 Oct 9.

引用本文的文献

2
Associations between Life's Essential 8 and gallstones among US adults: A cross-sectional study from NHANES 2017-2018.
PLoS One. 2024 Oct 30;19(10):e0312857. doi: 10.1371/journal.pone.0312857. eCollection 2024.
4
Different types and numbers metabolic abnormalities and risk of gallbladder stone disease in adults.
Front Nutr. 2024 Sep 9;11:1443575. doi: 10.3389/fnut.2024.1443575. eCollection 2024.
5
Causal association between metabolic syndrome and cholelithiasis: a Mendelian randomization study.
Front Endocrinol (Lausanne). 2023 Jun 9;14:1180903. doi: 10.3389/fendo.2023.1180903. eCollection 2023.
6
Complex impacts of gallstone disease on metabolic syndrome and nonalcoholic fatty liver disease.
Front Endocrinol (Lausanne). 2022 Nov 23;13:1032557. doi: 10.3389/fendo.2022.1032557. eCollection 2022.
7
Analysis of Sphingolipids in Pediatric Patients with Cholelithiasis-A Preliminary Study.
J Clin Med. 2022 Sep 23;11(19):5613. doi: 10.3390/jcm11195613.
8
Blood and Urinary Biomarkers of Antipsychotic-Induced Metabolic Syndrome.
Metabolites. 2022 Aug 5;12(8):726. doi: 10.3390/metabo12080726.

本文引用的文献

1
Evidence-based clinical practice guidelines for cholelithiasis 2016.
J Gastroenterol. 2017 Mar;52(3):276-300. doi: 10.1007/s00535-016-1289-7. Epub 2016 Dec 10.
3
Determinants for gallstone formation - a new data cohort study and a systematic review with meta-analysis.
Scand J Gastroenterol. 2016 Oct;51(10):1239-48. doi: 10.1080/00365521.2016.1182583. Epub 2016 May 27.
5
Prevalence of the metabolic syndrome in the United States, 2003-2012.
JAMA. 2015 May 19;313(19):1973-4. doi: 10.1001/jama.2015.4260.
6
The association of metabolic syndrome and its factors with gallstone disease.
BMC Fam Pract. 2014 Jul 29;15:138. doi: 10.1186/1471-2296-15-138.
7
A comprehensive review on metabolic syndrome.
Cardiol Res Pract. 2014;2014:943162. doi: 10.1155/2014/943162. Epub 2014 Mar 11.
8
The effects of serum cholesterol, LDL, and HDL levels on gallstone cholesterol concentration.
Pak J Med Sci. 2013 Jan;29(1):187-90. doi: 10.12669/pjms.291.2798.
9
Metabolic syndrome and gallstone disease.
World J Gastroenterol. 2012 Aug 21;18(31):4215-20. doi: 10.3748/wjg.v18.i31.4215.
10
Epidemiology of gallbladder disease: cholelithiasis and cancer.
Gut Liver. 2012 Apr;6(2):172-87. doi: 10.5009/gnl.2012.6.2.172. Epub 2012 Apr 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验